Evidence map›Paper›PMID 27166517›Full record

ArticleeLife2016

Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.

Karthikeyani Chellappa, Poonamjot Deol, Jane R Evans, Linh M Vuong, Gang Chen, Nadege Briançon, Eugene Bolotin, Christian Lytle, Meera G Nair, Frances M Sladek

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of HNF4α in adenocarcinoma.Biochemical Society transactions · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DNA methylation in necrotizing enterocolitis.Expert reviews in molecular medicine · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Major roles of the circadian clock in cancer.Cancer biology & medicine · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Karthikeyani ChellappaDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
Poonamjot DeolDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
Jane R EvansDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
Linh M VuongDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
Gang ChenDivision of Biomedical Sciences, University of California, Riverside, Riverside, United States.
Nadege BriançonDepartment of Cell Biology, Harvard Medical School, Boston, United States.
Eugene BolotinDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
Christian LytleDivision of Biomedical Sciences, University of California, Riverside, Riverside, United States.
Meera G NairDivision of Biomedical Sciences, University of California, Riverside, Riverside, United States.
Frances M SladekDepartment of Cell Biology and Neuroscience, University of California, Riverside, Riverside, United States.
University of California, Riverside · USHarvard University · USUniversity of Pennsylvania · US

Funding

Research Training in Environmental ToxicologyT32ES018827 · NIEHS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Yinsheng Wang · 2010 to 2026
$5.3M
REGULATION OF LIVER SPECIFIC GENE EXPRESSIONR01DK053892 · NIDDK · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI SLADEK, FRANCES M. · 1998 to 2015
$5.3M
RELM-alpha regulation of hookworm-induced lung inflammationR01AI091759 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI NAIR, MEERA GOH · 2011 to 2015
$2.0M
NIAID NIH HHS R01 AI091759NIDDK NIH HHS R01 DK053892NIEHS NIH HHS T32 ES018827
6 · The paper itself

Abstract

HNF4α has been implicated in colitis and colon cancer in humans but the role of the different HNF4α isoforms expressed from the two different promoters (P1 and P2) active in the colon is not clear. Here, we show that P1-HNF4α is expressed primarily in the differentiated compartment of the mouse colonic crypt and P2-HNF4α in the proliferative compartment. Exon swap mice that express only P1- or only P2-HNF4α have different colonic gene expression profiles, interacting proteins, cellular migration, ion transport and epithelial barrier function. The mice also exhibit altered susceptibilities to experimental colitis (DSS) and colitis-associated colon cancer (AOM+DSS). When P2-HNF4α-only mice (which have elevated levels of the cytokine resistin-like β, RELMβ, and are extremely sensitive to DSS) are crossed with Retnlb(-/-) mice, they are rescued from mortality. Furthermore, P2-HNF4α binds and preferentially activates the RELMβ promoter. In summary, HNF4α isoforms perform non-redundant functions in the colon under conditions of stress, underscoring the importance of tracking them both in colitis and colon cancer.

Indexed as

AnimalsColitisColonic NeoplasmsDisease Models, AnimalHepatocyte Nuclear Factor 4MiceProtein IsoformsHepatocyte Nuclear Factor 4Hnf4a protein, mouseProtein Isoformsalternative promoterscell biologychromosomescolitiscolon cancercolonic cryptsexon swap micegenesmousenuclear receptor

Identifiers

PMID27166517
PMCPMC4907689
OpenAlexW2352793274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.